Norman Armstrong Jr. (Norm)


Translate this page Share this page Print this page

T: +1 202 626 8979
F: +1 202 626 3737

Profile   |   News & Insights

Norman Armstrong, Jr., is a Partner in the Washington, D.C. office of King and Spalding and a member of the firm’s global Antitrust practice.   His practice focuses on representing foreign and domestic clients in a wide range of antitrust matters, including antitrust litigation, complex transactions and antitrust counseling and government civil and criminal investigations. Mr. Armstrong also represents clients on a wide array of consumer protection issues including false advertising and data privacy.

Mr. Armstrong is a former Deputy Director of the Federal Trade Commission’s Bureau of Competition.  As a Deputy Director of the FTC, he led three divisions that investigated mergers, acquisitions and joint ventures, as well as anticompetitive conduct, in a wide-array of industries including casinos, chemicals, consumer goods, entertainment, healthcare, pharmaceuticals, oil and gas, retail and technology. Mr. Armstrong handled some of the FTC’s most notable litigation matters in the last few years such as St. Luke Health System’s acquisition of Saltzer Medical Group, ProMedica Health System’s proposed acquisition of St. Luke’s Hospital, Phoebe Putney Health System’s proposed acquisition of Palmyra Park Hospital, and Whole Foods Market’s proposed acquisition of Wild Oats Market. He also oversaw many other important merger investigations, including Kroger’s proposed acquisition of Harris-Teeter, Google’s proposed acquisition of AdMob, Pepsi and The Coca-Cola Company’s proposed acquisitions of their largest bottlers, Dow Chemical’s proposed acquisition of Rohm and Haas, and Pfizer’s proposed acquisition of Wyeth. He also oversaw all oil and gas investigations, was the Co-Chair to the President’s Oil and Price Fraud Working Group, and briefed numerous members of Congress on oil and gas issues.

Mr. Armstrong is co-chair of the Antitrust Section of the American Bar Association’s Mergers and Acquisitions Committee and is a frequent lecturer on a wide range of substantive antitrust and litigation topics.